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Excessive exposure to noise damages the principal cochlear structures leading to
hearing impairment. Inflammatory and immune responses are central mechanisms in
cochlear defensive response to noise but, if unregulated, they contribute to inner ear
damage and hearing loss. Transforming growth factor β (TGF-β) is a key regulator
of both responses and high levels of this factor have been associated with cochlear
injury in hearing loss animal models. To evaluate the potential of targeting TGF-β as a
therapeutic strategy for preventing or ameliorating noise-induced hearing loss (NIHL),
we studied the auditory function, cochlear morphology, gene expression and oxidative
stress markers in mice exposed to noise and treated with TGF-β1 peptidic inhibitors
P17 and P144, just before or immediately after noise insult. Our results indicate that
systemic administration of both peptides significantly improved both the evolution of
hearing thresholds and the degenerative changes induced by noise-exposure in lateral
wall structures. Moreover, treatments ameliorated the inflammatory state and redox
balance. These therapeutic effects were dose-dependent and more effective if the
TGF-β1 inhibitors were administered prior to inducing the injury. In conclusion, inhibition
of TGF-β1 actions with antagonistic peptides represents a new, promising therapeutic
strategy for the prevention and repair of noise-induced cochlear damage.
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Introduction
Noise-induced hearing loss (NIHL) is the second most common form of deafness and constitutes
an important public health priority. Animal studies have shown that exposure to excessive noise
produces loss of hair cells, damage to the nerve synapses and loss of fibrocytes (Wang et al.,
2002; Hirose and Liberman, 2003), leading to sensorineural deafness. The severity of hearing loss
depends on noise characteristics (level, frequency, duration and temporal pattern) and genetic
susceptibility (Ohlemiller and Gagnon, 2007).
The main underlying molecular mechanisms in NIHL include free-radical formation and
oxidative stress, which activate cell death pathways in the cochlea, reduced cochlear blood
flow, disruption of the blood-labyrinth barrier, glutamate excitotoxicity, calcium imbalance
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and cochlear inflammation (Henderson et al., 2006; Le Prell et al.,
2007; Tan et al., 2013). Traditionally the cochlea was considered
to be immunologically isolated because of the existence of
the blood-labyrinth barrier. However, cochlear inflammation
has been associated with many situations causing hearing loss,
mainly otitis, autoimmune inner ear diseases and ototoxicity.
In addition, in the last years inflammation has emerged as a
key process in NIHL (Abi-Hachem et al., 2010; Tan et al.,
2013).
Noise activates the local immune response, with early
expression of proinflammatory cytokines in the cochlear resident
macrophages (Okano et al., 2008), spiral ligament fibrocytes,
strial cells and spiral ganglion neurons, including TNF-α,
IL-1β and IL-6 (Ichimiya et al., 2000; Satoh et al., 2002;
Fujioka et al., 2006; Tahera et al., 2006; Nakamoto et al.,
2012; Tan et al., 2013; Zhang et al., 2013). These cytokines,
along with other inflammatory mediators and cell adhesion
molecules, induce the infiltration of blood monocytes and
macrophages (Hirose et al., 2005; Tornabene et al., 2006)
to phagocytize debris, and the secretion of more cytokines
and growth factors (Yoshida et al., 1999). The inflammatory
response is intended to limit the damage and promote further
angiogenesis, fibroplasia and matrix synthesis, contributing
to repair (Park and Barbul, 2004). However, it could also
exacerbate pathological changes and produce bystander cell
injury. Therefore, noise damaged cochlea represent a target for
the application of otoprotective strategies based on controlling
inflammation.
TGF-β is a member of a pluripotent cytokine superfamily with
a key role in a variety of cellular processes such as proliferation,
differentiation, extracellular matrix deposition and apoptosis
during development, but also in postnatal stages (Massagué,
2012; Weiss and Attisano, 2013). In adult mammalians, TGF-β
family members participate in the maintenance of tissue
homeostasis, immune and inflammatory responses, angiogenesis
and fibrogenesis (Dünker and Krieglstein, 2000; Prud’homme,
2007). The mammalian genome encodes for three isoforms
(TGF-β 1, 2 and 3) with widespread tissue distribution and
similar signaling cascades through TGF-β receptor types I, II and
III (TGF-βR1, R2 and R3 or betaglycan) and SMAD2/3 proteins,
which translocate to the nucleus and regulate gene transcription
(Massagué, 2012). The three TGF-β isoforms are expressed in
the embryonic cochlea in rodents with distinct patterns: TGF-β2
in the cochlear epithelium (Sanford et al., 1997; Paradies et al.,
1998; Kim et al., 2006) and TGF-β1 and 3 in both epithelial
and mesenchymal tissues (Pelton et al., 1991; Frenz et al., 1992;
Paradies et al., 1998; Kim et al., 2006). Thus, TGF-β factors have
been described to be involved in otic capsule formation (Liu et al.,
2007), spiral ganglion formation and survival (Marzella et al.,
1999; Okano et al., 2005), and indirectly in cochlear tonotopic
organization (Son et al., 2012).
TGF-β1 is a master regulator of the immune response in
several tissues, controlling the differentiation, proliferation,
and activation of lymphocytes, macrophages and dendritic
cells by autocrine and paracrine mechanisms (Letterio, 2000).
Early after tissue damage, TGF-β1 modulates expression of
adhesion molecules and induces chemoattraction and activation
of leukocytes. These cells in turn secrete large amounts
of interleukins, including TGF-β, which in a subsequent
phase inhibit proliferation, differentiation and interleukin
production (Letterio, 2000; Prud’homme, 2007; Mantel
and Schmidt-Weber, 2011). Perturbations in the cytokine
balance could modify dual TGF-β actions and contribute
to immunopathology. In addition, several alterations of the
immune system have been described in mice with targeted
mutations in Tgfb1, including severe immune deregulation
and lethal postnatal multi-organ inflammatory syndrome
in Tgfb1 knock-out mice (Shull et al., 1992; Kulkarni et al.,
1993).
The role of TGF-β family factors in cochlear pathophysiology
is not fully understood. Recent in silico analysis of genes
relevant to hearing and deafness pointed to TGF-β1 as a
nodal molecule in non-syndromic deafness and otic capsule
development gene networks (Stamatiou and Stankovic, 2013).
Although TGF-β1 is not among the classical proinflammatory
cytokines, some studies in rodents have demonstrated an early
increase in its expression during cochlear damage induced
by aminoglycosides (Wissel et al., 2006), antigens (Satoh
et al., 2006) and otitis media (Ghaheri et al., 2007), followed
by a down-regulation as the response resolves, thus also
supporting the immunomodulator role of TGF-β in the cochlea.
Overexpression of TGF-β1 in the inner ear has also been
related to fibrosis after cochlear damage (Kawamoto et al.,
2003; Satoh et al., 2006), otosclerosis (Liu et al., 2007) and
cochlear implantation trauma (Eshraghi et al., 2013). To our
knowledge, there is no data concerning changes in TGF-β1
expression in NIHL, but a similar response to that observed in
ototoxic or autoimmune labyrinthitis can be expected. Therefore,
our hypothesis is that targeting TGF-β1 actions could help
modulate the inflammatory response during noise-induced
cochlear injury.
In this work we have studied the TGF-β signaling, gene
expression and oxidative balance in the cochlea after noise
exposure to clarify the role of TGF-β1 in NIHL. In addition,
we have explored the potential of targeting this factor with two
inhibitors of TGF-β1 as a therapeutic strategy to ameliorate
the noise-induced functional, molecular and morphological
changes.
Materials and Methods
Mouse Housing and Handling
Two month-old mice from three strains were used:
C57BL/6JOlaHsd (C57), CBA/CaOlaHsd (CBA) and outbred
HsdOla:MF1 (MF1) (Harlan Interfauna Ibérica, Spain). C57
mice are homozygous for a defective allele of the cadherin
23 gene (Cdh23ahl), and are especially vulnerable to noise
(Ohlemiller et al., 2000; Park et al., 2013). In contrast, CBA is a
normal hearing, noise injury-resistant strain (Wang et al., 2002;
Ohlemiller and Gagnon, 2007). In our hands, MF1 background
shows normal hearing and it is moderately resistant to NIHL
(Celaya et al., in preparation).
Mice were fed ad libitum with a standard diet and drinking
water, and controlled following FELASA recommendations.
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Animal experimentation was conducted in accordance with
Spanish and European legislation and approved by the Spanish
National Research Council (CSIC).
Hearing Evaluation and Noise Exposure
Hearing was evaluated by registering the auditory brainstem
response (ABR) as described (Cediel et al., 2006). Click
and 8--40 kHz tone burst stimuli (0.1 and 5 ms duration,
respectively) were generated with SigGenRP™software (Tucker-
Davis Technologies, Alachua, FL, USA) and presented
monaurally at 30 or 50 pulses per second each, from 90 to
10 dBs relative to sound pressure level (dB SPL) in 5--10 dB
SPL steps. The electrical response was amplified, recorded and
averaged (1000 and 750 stimulus-evoked responses for click and
tone burst, respectively). ABR thresholds were determined by
visual detection and defined as the lowest intensity to elicit a
reliable ABR wave with peaks I to IV clearly visible and medium
peak amplitude over 200 nV. Peak and interpeak latencies were
determined in the ABR trace in response to 20 dB SPL over the
click evoked threshold.
The efficacy of TGF-β inhibitors was evaluated in a NIHL
micemodel. Briefly, consciousmice were confined in a wiremesh
cage in the center of a reverberant chamber acoustically designed
to reach maximum sound level with minimum deviation in the
central exposure area (Cobo et al., 2009) and exposed to violet
swept sine (VS) noise, at 100--120 dB SPL for short (30 min) or
long (12 h) periods. VS noise was that was repeated during the
30 min of exposure.
VS noise was designed with Wavelab Lite software (Steinberg
Media Technologies GmbH, Hamburg, Germany). It consists in
a 10 s linear sweep in frequency, with a spectrum biased towards
high frequencies (frequency range 2--20 kHz, VS2--20)and
presented with a linear-with-frequency gain to compensate for
the high frequency losses inside the chamber (Cobo et al.,
2009; Sanz et al., 2015). The effect of noise exposure on
hearing was evaluated with ABR tests as described above. The
audiogram included tones from 8 to 40 kHz because exposure
to noise of certain frequencies induces threshold shifts in
octaves above those frequencies (Ou et al., 2000a,b; Sanz et al.,
2015).
Drug Administration
Two chemically synthesized TGF-β inhibitors (P17 and
P144) with 95% purity were used in the study (DIGNA
Biotech, Pamplona, Spain). P17 (KRIWFIPRSSWYERA) is
a soluble hydrophilic peptide derived from a phage library
(Dotor et al., 2007), with 100% relative binding affinity
for TGF-β1, 80% for TGF-β2 and 30% for TGF-β3 (Gil-
Guerrero et al., 2008). P144 (TSLDASIIWAMMQN) is a poorly
soluble hydrophobic peptide derived from the sequence of the
extracellular region of TGF-β type III receptor and specifically
designed to block the interaction with TGF-β1 (Ezquerro et al.,
2003).
Peptides stored at −80◦C were gently defrosted, diluted
in saline and sonicated (P144) until a clear solution was
obtained. Peptides were administered intraperitoneally at
doses ranging from 2.5 to 10 mg/kg, once or twice daily.
These doses were shown to be effective in animal models
of inflammation and fibrosis as mentioned before. Control
mice were injected IP with a similar volume of saline
(0.1 ml/10 g).
Cochlear Morphology
At the end of every experiment, cochlear samples were taken
for morphological evaluation. Cochlear samples were processed
to obtain 5 µm thick paraffin sections following standard
procedures. Cochlear morphology was studied in cresyl-violet
(Fluka; Sigma Aldrich) stained sections with an Axiophot Zeiss
microscope equipped with an Olympus DP70 digital camera as
previously described (Riquelme et al., 2010).
Gene Expression and Protein Analysis
When indicated, protein and gene expression were measured
by Western blotting and reverse transcription coupled to
quantitative PCR Data shown are representative of those found
in the different mouse strains studied whenever there were no
observable differences due to mouse background. For protein
analysis, cochlear extracts were prepared as reported (Sanchez-
Calderon et al., 2010). Protein concentration was determined
using a Micro BCA Protein Assay Kit (Pierce Biotechnology,
Inc., Rockford, IL USA) with BSA as the standard. Cochlear
proteins were subjected to gel electrophoresis and transferred
to PVDF membranes in a Bio-Rad Trans Blot apparatus.
After incubation with a blocking solution, the membranes
were probed overnight at 4◦C with the following primary
antibodies: p-SMAD2 (Ser465/467) (Cell Signaling Technology,
Danvers, MA, USA), p-p38 MAPK (Thr180/Tyr182), NOX-4
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) each at a
1:1000 dilution and MnSOD (Merck Millipore, Billerica, MA,
USA; 1 µg/ml). Blots were re-probed with SMAD2/3 (Santa
Cruz Biotechnology, 1:1000), p38α (Santa Cruz Biotechnology,
1:1000), β-actin (Sigma-Aldrich Corp. St. Louis, MO, USA;
1:2500) or p44/42 MAPK (Cell Signaling Technology, 1:1000) as
loading controls. Antibodies were prepared in TTBS containing
5% BSA for phosphorylation-specific antibodies or non-fat dried
milk for others. Themembranes were washed and incubated with
the corresponding peroxidase-conjugated secondary antibodies
for 1 h at room temperature. Immunoreactive bands were
visualized by enhanced chemiluminescence (GE Healthcare Bio-
Sciences, Pittsburgh, PA, USA) using X-ray films (Agfa, Mortsel,
Belgium), and the bands were quantified by densitometry with
NIH ImageJ software. Different exposure times were used to
ensure that bands were not saturated.
For gene expression studies, cochlear samples were processed
for RT-qPCR as reported (Rodríguez-de la Rosa et al.,
2014). TaqMan MGB probes were obtained from Assay-by-
DesignSM (Applied Biosystems) for amplification of Tgfb1, Tgfb2,
TgfbR1 and TgfbR2 genes. The ribosomal phosphoprotein P0
(Rplp0) was used as endogenous control gene. The relative
quantification values (RQ) between noise exposed and non-
exposed mice were determined by the 2−∆∆Ct method as
reported (Sanchez-Calderon et al., 2010), where ∆∆Ct =
∆Ctexposed −∆Ctnon-exposed, and ∆Ct = Cttarget − Ctendogenous.
Data were expressed as log10RQ mean.
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Statistical Analysis
For ABR and Western blot results, statistical analysis was
performed using IBM SPSS software (v.19.0). RT-qPCR data
were analyzed using the Integromics Real Time StatMiner
software package.1 Data were expressed as mean ± standard
error (SEM), and the results were considered significant at
p ≤ 0.05. Statistical significance was estimated by different tests
for ABR, western blot and qRT-PCR data, which are specified in
the figure legends.
Results
Noise Exposure Induces Changes in TGF-β
Signaling, Gene Expression and Oxidative
Balance in the Cochlea
Exposure to high level (100--120 dB SPL) VS2--20 noise
induced a notably temporal threshold shift in the first 24 h
after exposure and a gradual but limited recovery of ABR
thresholds. The severity of hearing loss is related to noise
intensity, with VS2--20 noise at 110 or 120 dB SPL inducing
permanent changes that suggest irreversible cochlear damage
(Figure 1A).
Next, the expression of Tgfb related genes (Tgfb1, Tgfb2,
TgfbR1 and TgfbR2) was studied in cochlear samples that
were taken 4 and 24 h after challenge with VS2--20 noise
at 110 dB SPL for 30 min. In general, RT-qPCR expression
profiles of Tgfb related genes in noise exposed mice showed
homogeneous distribution of Ct values and a higher correlation
Pearson index compared to non-exposed controls. A statistical
significant increase in the cochlear expression of Tgfb1 was
observed in mice exposed to noise 4 h after damage compared
to non-exposed controls, (RQ value of 3.2 ± 0.5, p = 0.03).
One day after exposure, a simultaneous increase in Tgfb1 and
TgfbR1 and a decrease in Tgfb2 and TgfbR2 gene expression
was observed in exposed mice compared to controls, although
the change was statistically significant only for TgfbR1 (RQ
value of 1.2 ± 0.07, p = 0.008) (Figure 1B). In addition,
p-SMAD2 protein levels, which propagate de TGF-β1 signal,
as well as p-p38α, NOX-4 and MnSOD, which are related to
cellular stress and oxidation, were determined prior to and
1, 3 and 14 days after noise exposure. Our results indicate
a moderate and progressive increase in the phosphorylation
of SMAD2 (ratio p-SMAD2/SMAD2/3) after noise exposure,
compared to baseline values, although without statistically
significant differences (Figure 1C). In addition, the levels of
other stress-related molecules such as phospho-p38α, NOX-
4 and MnSOD were also elevated in cochleae after noise
damage, confirming the role of oxidative stress in the
pathophysiology of NIHL. A statistically significant increase in
the levels of the antioxidant enzyme MnSOD was observed
in the first 24 h after exposure, whereas phosphorylation
of p-38α MAPK rose significantly 2 weeks after injury. No
differences were observed due to mouse strain (data not
shown).
1http://www.integromics.com/genomics-data-analysis/pcr-analysis
These results confirm that inflammation and oxidative stress
are key underlying mechanisms in NIHL and show that
TGF-β1 plays a role in cochlear response to noise injury. In
this context, the use of TGF-β1 inhibitors could represent a
therapeutic strategy for ameliorating NIHL. To evaluate the
safety profile and the efficacy of TGF-β1 inhibitor peptides P17
and P144 in the prevention and treatment of NIHL, different
experiments were carried out and they are summarized in
Table 1.
TGF-β1 Inhibitors Reduce Functional and
Morphological Alterations After Noise-Exposure
Safety Assessment of P17 and P144
Initially, the safety of treatment with TGF-β1 inhibitors was
evaluated. Systemic administration of either P17 or P144 peptides
at doses ranging from 2.5 to 10 mg/kg/24 h for 15 days in
MF1 and C57 mice was well-tolerated. None of the treated mice
showed signs of systemic toxicity nor did they die, confirming
previous reports in mice and rats (Ezquerro et al., 2003;
Arribillaga et al., 2011; Baltanás et al., 2013). With regard to
hearing, treatment with P17 and P144 did not increase ABR
thresholds or peak latencies, and no significant differences were
observed between drug-treated and saline control mice (Table 2).
In addition, cochlear samples were taken after treatments to
evaluate inner ear morphology. No gross alterations were found
in the organ of Corti, spiral ganglion and stria vascularis,
confirming the non-ototoxic and safe profile of both peptides
(data not shown).
Pretreatment with P17 and P144 Reduces Threshold
Shift After Noise Exposure
The potential of TGF-β1 inhibitors in preventing NIHL was
evaluated by treating mice with P17 and P144 at 2.5 mg/kg/24 h
or with saline at 0.1 ml/10 g/24 h for 15 days and then exposing
them to VS2--20 noise at 100 dB SPL. ABR was performed
before the treatment, and 1 day, 1, 2, 3 and 4 weeks after noise
exposure. The experimental procedure was performed on mice
from two genetic backgrounds, MF1 and C57, with different
susceptibilities to noise damage. Under all the conditions studied,
click thresholds did not change after treatment with P17 or P144,
confirming the safety profile.
Mice treated with P17, P144 or saline showed a similar ABR
temporal pattern in response to noise; a statistically significant
increase in ABR thresholds was observed 1 day after noise
exposure when compared to baseline values in the three groups
(paired T test, p ≤ 0.001), which was followed by a gradual
decrease during the first 2 weeks and permanent threshold
shifts from this moment on (Figure 2A). Compared to saline
treatment, systemic injection of P144 and P17 attenuated the
threshold shift that occurred in the first day after noise damage,
and ameliorated hearing recovery in the following weeks. The
preventive effect was more evident in MF1 than in C57 mice,
the former showing statistically significant differences 1 and
7 days after noise with both peptides compared to saline
(Figure 2A). Non-exposed mice of both strains did not show
significant changes of their ABR thresholds over the time (data
not shown).
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FIGURE 1 | Functional and molecular effects of noise exposure.
(A) Evolution of ABR click thresholds (mean ± SEM, in dB SPL) in C57
mice exposed to VS2--20 noise at 100 (white circles), 110 (gray) or 120
(black) dB SPL (n = 6 per group) for 30 min. Statistically significant
differences were found between mice exposed at 100 dB SPL and the
other groups (paired T test, ***p ≤ 0.001) and between 110 and 120
groups 1 day after exposure (#p ≤ 0.05). (B) Log_10RQ bar plot for
Tgb1, Tgfb2, TgfbR1 and TgfbR2 of cochlear samples, comparing noise
exposed (VS2--20 at 110 dB SPL) with non-exposed CBA mice. Increase
in the expression of Tgfb1 and TgfbR1 was observed in noise exposed
mice compared to non-exposed, the latter with a statistical signifficant
difference (p = 0.008, Limma test with Benjamini-Hochberg FDR method
and 0.05 adjusted p-value threshold). (C) Time course of p-p38/p38α,
p-SMAD2/SMAD2/3, NOX-4/β-actin and MnSOD/β-actin protein
expression ratios in the cochlea of noise-exposed C57 mice (VS2--20 at
110 dB SPL), before and 1, 3 and 14 days after noise exposure (n = 3
mice for each determination). Representative blots are shown. Data shown
as mean ± SEM. Statistically significant differences were found in p-p38,
NOX4 and MnSOD levels after noise exposure compared to baseline
values (paired T test, *p ≤ 0.05; **p ≤ 0.01).
TABLE 1 | Summary of the experiments performed with TGF-β1 inhibitors.
Study Strain Drug Dosage VS2--20 noise level/duration
Safety MF1, C57 P17, P144 2.5 mg/kg/24 h/15 days -
Pretreatment MF1, C57 P17, P144 2.5 mg/kg/24 h /15 days 100 dB SPL/12 h
Treatment C57 P17, P144 2.5 mg/kg/24 h /30 days 100 dB SPL /12 h
P17, P144 2.5 mg/kg/12 h/15 days 100 dB SPL /30 min
P17, P144 2.5 mg/kg/12 h/15 days 110 dB SPL /30 min
P17, P144 2.5 mg/kg/12 h/15 days 120 dB SPL /30 min
CBA P144 10 mg/kg/24 h/ 15 days 110 dB SPL /30 min
Different mouse strains and doses were used to study cochlear toxicity and efficacy of TGF-β1 inhibitor peptides P17 and P144 in the treatment of NIHL. MF1, HsdOla:MF1;
C57, C57BL/6JOlaHsd; CBA, CBA/CaOlaHsd; IP, intraperitoneal; VS2–20, Violet Swept Sine noise, frequency range 2–20 kHz.
Mice exposed to noise also showed an early statistically
significant increase in ABR latencies and a decrease in peak
amplitudes, especially in those corresponding to cochlea and
spiral ganglion (peak I), and then a recovery of baseline
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TABLE 2 | Analysis of hearing parameters after treatment with TGF-β1 inhibitors.
Strain Group ABR Parameter n Baseline After treatment
Mean SEM Mean SEM
SSF Threshold 41 1.79 42 2.68
IPL I-II 1.03 0.04 1.03 0.01
IPL I-IV 5 2.63 0.03 2.57 0.03
IPL II-IV 1.60 0.05 1.54 0.04
AMP I 1260.22 178.17 1231.64 177.30
MF1 P17 Threshold 39 2.45 36 2.04
IPL I-II 0.93 0.02 0.90 0.02
IPL I-IV 6 2.66 0.03 2.50 0.01
IPL II-IV 1.73 0.03 1.60 0.03
AMP I 1184.65 206.14 1488.37 220.30
P144 Threshold 36 0.82 34 0.82
IPL I-II 0.92 0.01 0.90 0.01
IPL I-IV 6 2.65 0.04 2.47 0.03
IPL II-IV 1.73 0.03 1.57 0.02
AMP I 1191.12 106.64 1411.01 115.87
SSF Threshold 43 1.22 39 1.63
IPL I-II 1.01 0.02 0.98 0.02
IPL I-IV 6 2.93 0.05 2.56 0.05
IPL II-IV 1.92 0.04 1.58 0.05
AMP I 1232.68 96.29 813.64 67.12
C57 P17 Threshold 43 1.22 42 1.63
IPL I-II 0.91 0.04 0.91 0.01
IPL I-IV 6 2.66 0.10 2.53 0.05
IPL II-IV 1.75 0.07 1.62 0.05
AMP I 974.21 127.11 730.55 98.24
P144 Threshold 41 1.63 40 1.22
IPL I-II 1.01 0.01 0.95 0.03
IPL I-IV 6 2.82 0.05 2.61 0.04
IPL II-IV 1.82 0.05 1.67 0.03
AMP I 1075.09 155.36 778.55 59.05
ABR thresholds (in dB SPL), interpeak latencies (in ms) and peak I amplitude (in nV) in response to click stimulus before and after systemic (intraperitoneal) treatment with
TGF-β1 inhibitor peptides P17 and P144 (at 2.5 mg/kg/24 h) or saline (at 0.1 ml/10 g/24 h) for 15 days in MF1 and C57 mice. No statistically significant differences were
found between baseline and post-treatment values (paired T-tests). MF1, HsdOla:MF1; C57, C57BL/6JOlaHsd IPL, interpeak latency; AMP, peak amplitude.
values in the following weeks (Figure 2B). Our results
showed that mice treated with TGF-β1 inhibitor peptides P17
and P144 exhibit a similar time-course of peak I latency
and amplitude after noise, compared to saline treatment,
suggesting that these molecules have a limited effect on nerve
conduction.
Cochlear samples were taken at the end of the experiment
(4 weeks after noise exposure) and processed for histological
evaluation. Typical morphological alterations were observed in
cochlear sections, including changes in stria vascularis, spiral
limbus, spiral ligament and organ of Corti, although specific
patterns of permanent damage were observed depending on
the mouse strain and cochlear region, as described previously
(Ohlemiller and Gagnon, 2007; Ohlemiller et al., 2011). In the
MF1 strain, mice exposed to noise and treated with saline
presented mainly a severe loss of spiral ligament fibrocytes
from basal to medium cochlear areas but also a collapsed
organ of Corti with lack of outer hair cells in the basal turn.
Treatment with TGF-β1 inhibitor peptides P17 and P144 reduced
cellular loss in the spiral ligament and favored maintenance of
outer hair cells in the organ of Corti, even in basal regions
(Figure 3).
Treatment with P17 and P144 Improves
Functional and Morphological Alterations After
Noise Exposure
Once the beneficial effect of TGF-β1 inhibitors in the prevention
of NIHL was confirmed, we explored their therapeutic properties
when administered after noise damage in C57 and CBA mouse
strains. C57 mice were exposed to VS2--20 noise at 100, 110 or
120 dB SPL, and then treated with TGF-β1 inhibitors or saline.
Cochlear samples were taken 1 and 3 days after noise for protein
level evaluation, and also at the end the experiment (28 days after
exposure) for morphological studies. In parallel, control non-
exposed animals were also evaluated.
Initial experiments using the same dosage as in pre-treatment
assays (2.5 mg/kg/24 h) for 15 or even 28 days after noise
exposure, did not show statistically significant differences
between drug-treated and saline-treated (0.1 ml/10 g/24 h)
experimental groups (data not shown). This dose is in the lower
range of the reported drug efficiency (Arribillaga et al., 2011)
and both molecules have a short life span (Ezquerro et al., 2003),
therefore the daily dose was doubled to 2.5 mg/kg/12 h and
administered for 15 days. Even under these conditions, P17,
P144 and saline treated mice showed similar ABR thresholds
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after exposure to 120 dB SPL noise. This result indicates that
TGF-β1 inhibitors were not able to restore hearing function after
an acoustic trauma (data not shown). However, in non-traumatic
exposures to noise intensities under 120 dB SPL, both inhibitors
clearly improved the time course of hearing loss beginning
the first week after noise-exposure. The favorable effect on
the evolution of ABR thresholds was more evident in mice
treated with P17 (Figures 4A,B), whereas P144 showed a subtle
therapeutic effect, possibly because of its poorer pharmacokinetic
profile. Statistically significant differences in ABR thresholds,
compared to saline-treated mice, were observed when P144
doses were increased to the maximum recommended dose of
10 mg/kg/24 h for 15 days (Figure 4C). Thus, TGF-β1 inhibitors
showed a dose-dependent therapeutic effect on NIHL.
As aforementioned, mice exposed to noise showed an early
increase in p-p38α, p-SMAD2 and MnSOD protein levels in the
cochlea regardless of treatment, in comparison to non-exposed
control mice. In agreement with functional results, mice treated
with TGF-β1 inhibitors showed significantly lower values of
p-p38α and p-SMAD2 1 day after damage and a higher MnSOD
level 3 days after insult when compared to saline-treated mice,
suggesting that these peptides favored an anti-inflammatory
and antioxidant state throughout TGF-β1 signalling inhibition
(Figure 5).
Cochlear samples were taken for gross histology evaluation
4 weeks after noise exposure. Similarly to pre-treatment assays,
treatment with TGF-β1 inhibitor peptides P17 and P144
attenuated the morphological alterations induced by VS2--20
noise compared to saline treated animals (data not shown).
Differences were especially observed in the lateral wall structures
and in the organ of Corti, depending on themouse strain. In CBA
mice, TGF-β1 inhibitors reduced the degenerative changes in the
spiral ligament and the loss of fibrocytes, whereas in C57 mice,
the protective effect was more evident in the organ of Corti, with
maintenance of outer hair cells even in basal regions (data not
shown).
Discussion
According to WHO, NIHL is an important medical concern in
developed countries and currently efforts are being focused on
preventing excessive noise exposure and on treating hearing loss
(updated February 2014).2
Noise exposure induces a series of well-characterized
morphological and functional changes in the cochlea, depending
especially on the noise level, frequency, duration and temporal
pattern (Wang et al., 2002; Hirose and Liberman, 2003;
Ohlemiller, 2006; Park et al., 2013). The principal pathogenic
mechanisms in NIHL include oxidative stress (Henderson et al.,
2006) and inflammatory response, with an early local expression
of cytokines and recruitment of immune cells (Tan et al., 2013),
As occurred in ototoxicity, molecules with antioxidant and anti-
inflammatory actions are being tested as potential otoprotective
compounds (Bas et al., 2012; Fetoni et al., 2013).
2http://www.who.int/mediacentre/factsheets/fs300/en/
FIGURE 2 | Evolution of hearing after administration of TGF-β1
inhibitors before noise exposure. (A) Evolution of ABR thresholds (mean ±
SEM, in dB SPL) in MF1 mice (n = 6 per group) treated with TGF-β1 inhibitors
P17 or P144 at 2.5 mg/kg/24 h/15 days, or saline, and exposed to 100 dB VS
noise overnight. Statistically significant differences (ANOVA with Bonferroni
post hoc test, p ≤ 0.05) were found between P17 (triangle, *p ≤ 0.05) or
P144 (square, #p ≤ 0.05, ##p ≤ 0.01,) and the saline group (circles), 1 and 7
days after exposure. (B) The evolution of peak I latency (mean ± SEM, in ms)
in P17 (black bars), P144 (gray bars) and saline (white bars) treated mice
showed a similar pattern. A statistically significant increase in peak I latency
was observed 1 day after noise exposure in the three groups (paired T test
compared to post-treatment values, **p ≤ 0.01).
The participation of the proinflammatory cytokines TNF-α,
IL-1β and IL-6 in the cochlea after noise exposure has been
reported (Ichimiya et al., 2000; Satoh et al., 2002; Fujioka
et al., 2006; Tahera et al., 2006; Nakamoto et al., 2012; Tan
et al., 2013), but the role of TGF-β is still undetermined.
TGF-β family factors are key regulators of the immune and
inflammatory response in several processes (reviewed in Mantel
and Schmidt-Weber, 2011). In fact, an early increase in TGF-
β expression in the inner ear has also been described in
ototoxicity, immuno-mediated hearing loss and chronic otitis
media (Satoh et al., 2006; Wissel et al., 2006; Ghaheri et al.,
2007).
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FIGURE 3 | Cochlear morphology in mice treated with TGF-β1
inhibitors before being exposed to noise. (A--C) Midmodiolar section (A)
and detail of the scala media from middle (B) and basal (C) turns of the
cochlea in a control non-exposed mouse, showing normal cytoarchitecture of
spiral limbus (SL), spiral ligament (SpL) and organ of Corti with the outer and
inner hair cells (D--I) Details of the spiral limbus, spiral ligament and organ of
Corti from a representative MF1 mouse pre-treated with saline (D,E), P17
(F,G) or P144 (H,I) before noise exposure. Mice treated with saline showed
loss of fibrocyte cells in the spiral ligament (arrows) in the basal and middle
turns of the cochlea and outer hair cells in the organ of Corti (asterisk) in the
basal turn. In contrast, mice receiving TGF-β1 inhibitors presented preserved
cochlear structures, with the presence of OHC even in the basal turn (arrows
in G,I). Scale bars: A, K 0.5 mm; (C--G), 100 µm. SG, spiral ganglion; SV,
scala vestibule; SM, scala media; ST, scala tympani; SL, spiral limbus; SpL,
spiral ligament; OHC, outer hair cells; IHC, inner hair cells.
In this work we show that in the first 24 h after noise
exposure there is an increase in Tgfb1 and TgfbR1 cochlear
gene expression, concomitantly with a decrease in Tgfb2 and
TgfbR2. These results point to the participation of TGF-β1
in the cochlear inflammatory response to noise injury, and
suggest that TGF-β1 could play a role in the initial inflammatory
phase. Thus, additional experiments from the group in a mice
model of NIHL found a statistically significant 3-fold change
in Tgfb1 expression 4 h after noise challenge, compared to
non-exposed animals (Celaya et al., in preparation). Similarly,
up-regulation of the proinflammatory cytokines TNFα, IL-1β
and IL-6 has been described to occur rapidly after noise
exposure, reaching maximum level 3--6 h after noise exposure
and maintaining high levels during the following 24--48 h
(Fujioka et al., 2006; Tornabene et al., 2006). This quick
inflammatory response presumably originates in resident cells,
including bone marrow-derived macrophages, spiral ganglion
cells and spiral ligament fibrocytes, but also from recruited
immune cells. Thus, Satoh et al. found an increase in TGF-β1
immunostaining in the infiltrated inflammatory cells 3 h after
the injection of keyhole limpet hemocyanin, which caused an
exacerbated immune response in the mouse cochlea. These
high levels of TGF-β1 persisted for 48 h and reverted to
normal after 7 days as the response resolves (Satoh et al.,
2006). TGF-β has been shown to possess dual actions in the
inflammatory response to damage, with both pro and anti-
inflammatory roles (Kawamoto et al., 2003; Sanjabi et al.,
2009). Therefore, we can speculate that the observed initial
release of the factor in the cochlea forms part of the early
proinflammatory phase of cochlear response to noise damage.
Indeed, our data show that its inhibition has an overall protective
effect.
In our experiments, noise also induced an activation of the
proinflammatory p38α MAPK in the cochlea. We studied the
ratio of phosphorylated to total kinase levels as an index of
activity in cochlear protein extracts, and we found an increase
at 24 h and 2 weeks after VS2--20 noise exposure in the saline-
treated mouse group. The activation of p38α after noise damage
and its correlation with temporal and permanent threshold
shifts have been previously reported in the cochlea of chinchilla
(Jamesdaniel et al., 2011) and mouse (Meltser et al., 2010; Maeda
et al., 2013).
We also confirmed elevated NOX-4 levels in the cochlea
1--3 days after noise exposure. NADPH oxidases (NOX)
are enzymes that transport electrons across the plasma
membrane and constitute an important source of superoxide
radicals. Excessive production of superoxide increases
levels of reactive oxygen and nitrogen species which could
damage DNA and disrupt lipid and protein molecules
leading to cell death by apoptosis (Henderson et al., 2006).
Oxidative stress is a common pathogenic mechanism in
cochlear damage secondary to noise, ototoxic drugs and
aging. Thus, an increase in the expression of NOX-1 and
NOX-4 isoforms and their regulatory subunits has been
described in fibrocytes, epithelial cells and neurons from mice
treated with cisplatin (Kim et al., 2010). In noise-exposed
rats, it has been observed an up-regulation of NOX-1 and
DUOX2 whereas NOX-3 was down-regulated (Vlajkovic et al.,
2013).
In parallel to NOX-4, our data also confirmed an elevation
of MnSOD protein level in the cochlea after noise damage
exposure. Superoxide dismutases are key antioxidant enzymes
directed toward the scavenging of free radicals to maintain
the oxidative balance, and low levels are associated with
an impaired response to cochlear damage in mice and rats
(Keithley et al., 2005; Ying and Balaban, 2009). In addition,
polymorphisms in the human SOD2 gene that codifies for
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FIGURE 4 | Administration of TGF-β1 inhibitors after noise exposure.
(A) Representative ABR waveforms in response to click stimulus in C57
exposed to VS2--20 noise at 110 dB SPL for 30 min and then treated with
TGF-β1 inhibitor P17 at 2.5 mg/kg/12 h or saline for 15 days. Bold lines
indicate the ABR threshold. (B) Evolution of click ABR thresholds (mean ±
SEM, in dB SPL) in C57 mice exposed to VS2--20 noise at 110 dB SPL for
30 min and then treated with TGF-β1 inhibitor P17 (triangles) at 2.5 mg/kg
or saline (circles) at 0.1 ml/10 g once (white symbols) or twice (black
symbols) daily for 15 days (n = 6 per group). Statistically significant
differences (paired T test, **p ≤ 0.01) were found between mice treated with
P17 at 2.5 mg/kg/12 h and saline treated mice. Similar results were
observed with P144 (data not shown). (C) Audiogram of CBA mice treated
with P144 (black squares) at 10 mg/kg/day for 15 days after noise exposure
(VS2--20 at 110 dB SPL, 30 min) showed statistically significant differences
(paired T test, *p ≤ 0.05, ***p ≤ 0.001) at the end of the treatment
compared to saline treated mice (black circles). Non-exposed mice (white
circles) maintained normal hearing thresholds throughout the study. Similar
results were observed with P17 treatment (data not shown).
MnSOD enzyme, have been related to NIHL predisposition
(Fortunato et al., 2004; Liu et al., 2010), suggesting that
this enzyme is critical during the cochlear response to noise
injury.
Taken together, our data confirm that inflammation and
oxidative stress are central events in the physiopathology
of NIHL and show that TGF-β1 participates in the early
phases. Therefore, blocking of this proinflammatory
cytokine could be useful in ameliorating pathological
changes in the cochlea after noise insult. In this study
we tested the therapeutic effect of TGF-β1 inhibitors P17
and P144 administered systemically both before and after
noise exposure to explore their potential in prevention
and repair situations, respectively. These peptides have
demonstrated a strong TGF-β inhibitory effect in animal
models of liver and pulmonary fibrosis and hypertension
(Ezquerro et al., 2003; Arribillaga et al., 2011; Baltanás
et al., 2013). In addition P144 has completed phase I and
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FIGURE 5 | Protein levels after noise exposure and treatment with
TGF-β1 inhibitor. Time course of phospo-p38/p38α,
phospho-SMAD2/SMAD2/3, NOX-4/MAPK and MnSOD/β-actin ratios relative
(%) to non-exposed mice (white bars), in cochlear samples of noise-exposed
(VS2--20 at 110 dB SPL) CBA mice (n = 3 mice for each determination) and
treated with TGF-β1 inhibitor P144 at 10 mg/kg/24 h/15 days (black) or saline
(gray). Representative blots are shown. Data are shown as mean ± SD.
Statistically significant differences were found in p-p38, NOX4 and MnSOD
levels after noise exposure compared to values in non-exposed mice (paired T
test, *p ≤ 0.05; **p ≤ 0.01). Noise induced statistically significant increases in
p-p38, p-SMAD2 and MnSOD ratios compared to non-exposed mice (paired T
test, *p ≤ 0.05; **p ≤ 0.01). Treatment with P144 showed significantly lower
levels of p-p38α and p-SMAD2 and higher levels of MnSOD compared to
saline-treated mice (paired T test, #p ≤ 0.05; ##p ≤ 0.01).
II clinical trial studies (NCT00656825, NCT00574613 from
http://clinicaltrials.gov/ct2/home) and it has been designated as
an orphan drug.
Systemic pre-treatment with P17 or P144 significantly
reduced the temporal threshold shift observed 1 day after noise
exposure. However, when the same dose of TGF-β1 inhibitors
were administered after noise damage, the therapeutic effect
was observed only after 1 week of treatment. Intraperitoneal
administration of drugs could achieve rapidly high cochlear levels
(Rivera et al., 2012). For example, steroids reach the highest
concentration in the mouse cochlea only 25 min after injection
(Kanzaki et al., 2012). On the other hand, up-regulation of
proinflammatory cytokines, including TGF-β1, occurs in the first
3--6 h after noise exposure (Fujioka et al., 2006; Tornabene et al.,
2006; Celaya et al., in preparation). Therefore, to reach effective
local levels in the acute phase of noise-induced inflammation,
drug delivery should be performed before or immediately after
exposure. We hypothesize that this is the reason why a similar
dose of TGF-β1 inhibitors (2.5 mg/kg/day/15 days) was more
effective if administered prior to noise exposure rather than
1 day afterwards. The therapeutic effect of TGF-β1 inhibitors
administered after noise exposure depended on the noise level
and also on the peptide dosages. Thus, P17 and P144 were
not able to improve the functional and structural damage that
occurred after acoustic trauma with noise levels of 120 dB SPL.
However, dose-dependent beneficial effects could be observed
when these peptides were administered after exposure to non-
traumatic 100 or 110 dB SPL noise. P17 induced a better recovery
of ABR thresholds when administered at 5 mg/kg daily for 15
consecutive days, whereas P144 required 10 mg/kg daily dose to
achieve similar effectiveness. This result might possibly reflect
the pharmacological characteristics of these peptides, since P144
has a poorer solubility in saline than P17 (Ezquerro et al.,
2003).
Concomitantly to functional improvement, mice treated with
TGF-β1 inhibitors presented more favorable antioxidant and
anti-inflammatory profiles than saline-treated mice. Thus, a
significant decrease in the activation of the stress-related kinase
p38α was observed in mice treated with TGF-β1 inhibitors
1 day after noise exposure compared to saline-treated mice,
suggesting that these peptides contribute to decrease the activity
of proinflammatory pathways after noise injury. Oxidative
imbalance by excessive formation of free radical species is one
of the main pathological mechanisms in NIHL (Henderson
et al., 2006). Treatment of NIHL with TGF-β1 inhibitors also
induces an increase in the levels of MnSOD compared to saline
controls, therefore contributing to the scavenging of free radicals
and recovery of the oxidative balance. Both the decrease in
p38α and the increase in MnSOD activities should provide
mice treated with TGF-β1 inhibitors a better resistance to
NIHL.
The morphological substrate for this therapeutic effect seems
to be the cochlear lateral wall, since noise-exposed mice
treated with TGF-β1 inhibitors showed reduced pathological
alterations in the spiral ligament when compared to those
receiving saline. It has been well documented that noise
exposure results in disruption of the lateral wall and causes
strial edema and apoptosis of fibrocytes of the spiral ligament
(Hirose and Liberman, 2003). The lateral wall is a central
structure in the modulation of cochlear inflammatory and
immune responses to insult, with resident macrophages and
also fibrocytes secreting cytokines that modify the permeability
of the blood-labyrinth barrier and attract immune cells from
the vasculature. It is likely that TGF-β1 levels are increased
in the spiral ligament after noise exposure, therefore acting
as a proinflammatory cytokine. In addition, it has been
reported that mononuclear phagocytes migrate into the murine
cochlea after acoustic trauma (Hirose et al., 2005) and that
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infiltrated inflammatory cells express TGF-β after antigen
challenge (Satoh et al., 2006). Thus blocking this factor could
be a good strategy for ameliorating noise-induced cochlear
changes.
On the other hand, it is known that TGF-β1 stimulates the
production of collagen fibers in fibrocytes and that excessive
collagen synthesis could be deleterious. In this context, the
inhibition of TGF-β1 has shown important effects on fibrotic
diseases, including hepatic (Ezquerro et al., 2003), pulmonary
(Arribillaga et al., 2011), myocardial (Hermida et al., 2009), skin
(Santiago et al., 2005) and periprosthetic fibrosis (San-Martin
et al., 2010). Therefore, reduction of excessive collagen formation
in the spiral ligament after noise exposure could be a secondary
beneficial action of TGF-β1 inhibitors in the cochlea.
In summary, in this study we show that TGF-β1 plays a central
role in cochlear response to excessive noise exposure and that
treatment with TGF-β1 inhibitors ameliorates NIHL.
Authors and Contributors
SM-C, acquisition of data, analysis and interpretation of data,
drafting and revising the article, final approval of the version
to be published. LR-dlR, acquisition of data, analysis and
interpretation of data, drafting the article. JC, analysis and
interpretation of data, drafting the article. GC, acquisition of
data. TR, analysis and interpretation of data, revising the article,
final approval of the version to be published. IV-N, design of
the experiments, analysis and interpretation of data, revising the
article, final approval of the version to be published.
Acknowledgments
We would like to thank our colleagues from the Neurobiology
of Hearing group for their generous sharing of techniques and
information. We also warmly thank Drs. Miguel Quintanilla
(CSIC), Gemma Rodriguez-Tarduchy (CSIC), Javier Dotor
(DIGNA Biotech) and Pablo Ortiz (OWL) for helpful
discussions. This study was supported by grants from the
Ministerio de Ciencia e Inovación (SAF2011-24391), DIGNA
Biotech, the 7th Framework Programme projects AFHELO
and TARGEAR for IVN and FIS PI 10/00394 for TR. SM-C,
LRdR and GC hold contracts from CIBERER (SM, LRdR) and
CSIC Junta para la Ampliación de Estudios programs (GC). The
authors declare that they have no conflicts of interest.
Abbreviations
ABR, Auditory brainstem response; NIHL, Noise-induced
hearing loss; OHC, Outer hair cells; TGF-β, Transforming
growth factor beta; VS, Violet swept sine.
References
Abi-Hachem, R. N., Zine, A., and Van DeWater, T. R. (2010). The injured cochlea
as a target for inflammatory processes, initiation of cell death pathways and
application of related otoprotectives strategies. Recent Pat. CNS Drug Discov. 5,
147--163. doi: 10.2174/157488910791213121
Arribillaga, L., Dotor, J., Basagoiti, M., Riezu-Boj, J. I., Borrás-Cuesta, F.,
Lasarte, J. J., et al. (2011). Therapeutic effect of a peptide inhibitor of TGF-
beta on pulmonary fibrosis. Cytokine 53, 327--333. doi: 10.1016/j.cyto.2010.
11.019
Baltanás, A., Miguel-Carrasco, J. L., San José, G., Cebrián, C., Moreno, M. U.,
Dotor, J., et al. (2013). A synthetic peptide from transforming growth factor-
β_1 type III receptor inhibits NADPH oxidase and prevents oxidative stress
in the kidney of spontaneously hypertensive rats. Antioxid. Redox Signal. 19,
1607--1618. doi: 10.1089/ars.2012.4653
Bas, E., Van De Water, T. R., Gupta, C., Dinh, J., Vu, L., Martinez-Soriano, F.,
et al. (2012). Efficacy of three drugs for protecting against gentamicin-induced
hair cell and hearing losses. Br. J. Pharmacol. 166, 1888--1904. doi: 10.1111/j.
1476-5381.2012.01890.x
Cediel, R., Riquelme, R., Contreras, J., Díaz, A., and Varela-Nieto, I. (2006).
Sensorineural hearing loss in insulin-like growth factor I-null mice: a new
model of human deafness. Eur. J. Neurosci. 23, 587--590. doi: 10.1111/j.1460-
9568.2005.04584.x
Cobo, P., Murillo-Cuesta, S., Cediel, R., Moreno, A., Lorenzo-García, P., and
Varela-Nieto, I. (2009). Design of a reverberant chamber for noise exposure
experiments with small animals. Appl. Acoust. 70, 1034--1040. doi: 10.1016/j.
apacoust.2009.03.005
Dotor, J., López-Vázquez, A. B., Lasarte, J. J., Sarobe, P., García-Granero, M.,
Riezu-Boj, J. I., et al. (2007). Identification of peptide inhibitors of transforming
growth factor beta 1 using a phage-displayed peptide library. Cytokine 39,
106--115. doi: 10.1016/j.cyto.2007.06.004
Dünker, N., and Krieglstein, K. (2000). Targeted mutations of transforming
growth factor-beta genes reveal important roles in mouse development and
adult homeostasis. Eur. J. Biochem. 267, 6982--6988. doi: 10.1046/j.1432-1327.
2000.01825.x
Eshraghi, A. A., Gupta, C., Van De Water, T. R., Bohorquez, J. E., Garnham, C.,
Bas, E., et al. (2013). Molecular mechanisms involved in cochlear implantation
trauma and the protection of hearing and auditory sensory cells by inhibition of
c-Jun-N-terminal kinase signaling. Laryngoscope 123(Suppl. 1), S1--S14. doi: 10.
1002/lary.23902
Ezquerro, I. J., Lasarte, J. J., Dotor, J., Castilla-Cortázar, I., Bustos, M., Peñuelas, I.,
et al. (2003). A synthetic peptide from transforming growth factor beta type III
receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury.
Cytokine 22, 12--20. doi: 10.1016/s1043-4666(03)00101-7
Fetoni, A. R., De Bartolo, P., Eramo, S. L., Rolesi, R., Paciello, F., Bergamini,
C., et al. (2013). Noise-induced hearing loss (NIHL) as a target of oxidative
stress-mediated damage: cochlear and cortical responses after an increase in
antioxidant defense. J. Neurosci. 33, 4011--4023. doi: 10.1523/JNEUROSCI.
1009-13.2013
Fortunato, G., Marciano, E., Zarrilli, F., Mazzaccara, C., Intrieri, M., Calcagno, G.,
et al. (2004). Paraoxonase and superoxide dismutase gene polymorphisms and
noise-induced hearing loss. Clin. Chem. 50, 2012--2018. doi: 10.1373/clinchem.
2004.037788
Frenz, D. A., Galinovic-Schwartz, V., Liu, W., Flanders, K. C., and Van De Water,
T. R. (1992). Transforming growth factor beta 1 is an epithelial-derived signal
peptide that influences otic capsule formation. Dev. Biol. 153, 324--336. doi: 10.
1016/0012-1606(92)90117-y
Fujioka, M., Kanzaki, S., Okano, H. J., Masuda, M., Ogawa, K., and Okano,
H. (2006). Proinflammatory cytokines expression in noise-induced damaged
cochlea. J. Neurosci. Res. 83, 575--583. doi: 10.1002/jnr.20764
Ghaheri, B. A., Kempton, J. B., Pillers, D. A., and Trune, D. R. (2007). Cochlear
cytokine gene expression in murine chronic otitis media. Otolaryngol. Head
Neck Surg. 137, 332--337. doi: 10.1016/j.otohns.2007.03.020
Gil-Guerrero, L., Dotor, J., Huibregtse, I. L., Casares, N., López-Vázquez, A. B.,
Rudilla, F., et al. (2008). In vitro and in vivo down-regulation of regulatory T
cell activity with a peptide inhibitor of TGF-beta1. J. Immunol. 181, 126--135.
doi: 10.4049/jimmunol.181.1.126
Henderson, D., Bielefeld, E. C., Harris, K. C., and Hu, B. H. (2006). The role
of oxidative stress in noise-induced hearing loss. Ear Hear. 27, 1--19. doi: 10.
1097/01.aud.0000191942.36672.f3
Frontiers in Aging Neuroscience | www.frontiersin.org 11 March 2015 | Volume 7 | Article 32
Murillo-Cuesta et al. Targeting TGF-β1 reduces noise-induced damage
Hermida, N., López, B., González, A., Dotor, J., Lasarte, J. J., Sarobe, P., et al.
(2009). A synthetic peptide from transforming growth factor-beta1 type III
receptor prevents myocardial fibrosis in spontaneously hypertensive rats.
Cardiovasc. Res. 81, 601--609. doi: 10.1093/cvr/cvn315
Hirose, K., Discolo, C. M., Keasler, J. R., and Ransohoff, R. (2005). Mononuclear
phagocytes migrate into the murine cochlea after acoustic trauma. J. Comp.
Neurol. 489, 180--194. doi: 10.1002/cne.20619
Hirose, K., and Liberman, M. C. (2003). Lateral wall histopathology and
endocochlear potential in the noise-damaged mouse cochlea. J. Assoc. Res.
Otolaryngol. 4, 339--352. doi: 10.1007/s10162-002-3036-4
Ichimiya, I., Yoshida, K., Hirano, T., Suzuki, M., and Mogi, G. (2000). Significance
of spiral ligament fibrocytes with cochlear inflammation. Int. J. Pediatr.
Otorhinolaryngol. 56, 45--51. doi: 10.1016/s0165-5876(00)00408-0
Jamesdaniel, S., Hu, B., Kermany, M. H., Jiang, H., Ding, D., Coling, D., et al.
(2011). Noise induced changes in the expression of p38/MAPK signaling
proteins in the sensory epithelium of the inner ear. J. Proteomics 75, 410--424.
doi: 10.1016/j.jprot.2011.08.007
Kanzaki, S., Fujioka, M., Yasuda, A., Shibata, S., Nakamura, M., Okano, H. J.,
et al. (2012). Novel in vivo imaging analysis of an inner ear drug delivery
system in mice: comparison of inner ear drug concentrations over time
after transtympanic and systemic injections. PLoS One 7:e48480. doi: 10.
1371/journal.pone.0048480
Kawamoto, K., Yagi, M., Stöver, T., Kanzaki, S., and Raphael, Y. (2003). Hearing
and hair cells are protected by adenoviral gene therapy with TGF-α1 and
GDNF.Mol. Ther. 7, 484--492. doi: 10.1016/s1525-0016(03)00058-3
Keithley, E. M., Canto, C., Zheng, Q. Y., Wang, X., Fischel-Ghodsian, N., and
Johnson, K. R. (2005). Cu/Zn superoxide dismutase and age-related hearing
loss. Hear. Res. 209, 76--85. doi: 10.1016/j.heares.2005.06.009
Kim, H. J., Kang, K. Y., Baek, J. G., Jo, H. C., and Kim, H. (2006). Expression of
TGFbeta family in the developing internal ear of rat embryos. J. Korean Med.
Sci. 21, 136--142. doi: 10.3346/jkms.2006.21.1.136
Kim, H. J., Lee, J. H., Kim, S. J., Oh, G. S., Moon, H. D., Kwon, K. B.,
et al. (2010). Roles of NADPH oxidases in cisplatin-induced reactive oxygen
species generation and ototoxicity. J. Neurosci. 30, 3933--3946. doi: 10.
1523/JNEUROSCI.6054-09.2010
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C.,
et al. (1993). Transforming growth factor beta 1 null mutation in mice causes
excessive inflammatory response and early death. Proc. Natl. Acad. Sci. U S A
90, 770--774. doi: 10.1073/pnas.90.2.770
Le Prell, C. G., Yamashita, D., Minami, S. B., Yamasoba, T., and Miller, J. M.
(2007). Mechanisms of noise-induced hearing loss indicate multiple methods
of prevention. Hear. Res. 226, 22--43. doi: 10.1016/j.heares.2006.10.006
Letterio, J. J. (2000). Murine models define the role of TGF-beta as a master
regulator of immune cell function. Cytokine Growth Factor Rev. 11, 81--87.
doi: 10.1016/s1359-6101(99)00031-3
Liu, W., Butts, S., Kim, H., and Frenz, D. A. (2007). Negative regulation of otic
capsule chondrogenesis: it can make you Smad. Ann. N Y Acad. Sci. 1116,
141--148. doi: 10.1196/annals.1402.005
Liu, Y. M., Li, X. D., Guo, X., Liu, B., Lin, A. H., and Rao, S. Q. (2010). Association
between polymorphisms in SOD1 and noise-induced hearing loss in
Chinese workers. Acta Otolaryngol. 130, 477--486. doi: 10.3109/000164809032
53587
Maeda, Y., Fukushima, K., Omichi, R., Kariya, S., and Nishizaki, K. (2013).
Time courses of changes in phospho- and total- MAP kinases in the cochlea
after intense noise exposure. PLoS One 8:e58775. doi: 10.1371/journal.pone.00
58775
Mantel, P. Y., and Schmidt-Weber, C. B. (2011). Transforming growth factor-
beta: recent advances on its role in immune tolerance.Methods Mol. Biol. 677,
303--338. doi: 10.1007/978-1-60761-869-0_21
Marzella, P. L., Gillespie, L. N., Clark, G. M., Bartlett, P. F., and Kilpatrick, T. J.
(1999). The neurotrophins act synergistically with LIF and members of the
TGF-beta superfamily to promote the survival of spiral ganglia neurons in vitro.
Hear. Res. 138, 73--80. doi: 10.1016/s0378-5955(99)00152-5
Massagué, J. (2012). TGFβ signalling in context. Nat. Rev. Mol. Cell Biol. 13,
616--630. doi: 10.1038/nrm3434
Meltser, I., Tahera, Y., and Canlon, B. (2010). Differential activation of
mitogen-activated protein kinases and brain-derived neurotrophic factor after
temporary or permanent damage to a sensory system. Neuroscience 165,
1439--1446. doi: 10.1016/j.neuroscience.2009.11.025
Nakamoto, T., Mikuriya, T., Sugahara, K., Hirose, Y., Hashimoto, T., Shimogori,
H., et al. (2012). Geranylgeranylacetone suppresses noise-induced expression
of proinflammatory cytokines in the cochlea. Auris Nasus Larynx 39, 270--274.
doi: 10.1016/j.anl.2011.06.001
Ohlemiller, K. K. (2006). Contributions of mouse models to understanding of age-
and noise-related hearing loss. Brain Res. 1091, 89--102. doi: 10.1016/j.brainres.
2006.03.017
Ohlemiller, K. K., and Gagnon, P. M. (2007). Genetic dependence of cochlear cells
and structures injured by noise. Hear. Res. 224, 34--50. doi: 10.1016/j.heares.
2006.11.005
Ohlemiller, K. K., Rosen, A. D., Rellinger, E. A., Montgomery, S. C., and Gagnon,
P. M. (2011). Different cellular and genetic basis of noise-related endocochlear
potential reduction in CBA/J and BALB/cJ mice. J. Assoc. Res. Otolaryngol. 12,
45--58. doi: 10.1007/s10162-010-0238-z
Ohlemiller, K. K., Wright, J. S., and Heidbreder, A. F. (2000). Vulnerability to
noise-induced hearing loss in ‘middle-aged’ and young adult mice: a dose-
response approach in CBA, C57BL and BALB inbred strains. Hear. Res. 149,
239--247. doi: 10.1016/s0378-5955(00)00191-x
Okano, T., Nakagawa, T., Kita, T., Kada, S., Yoshimoto, M., Nakahata, T., et al.
(2008). Bone marrow-derived cells expressing Iba1 are constitutively present
as resident tissue macrophages in the mouse cochlea. J. Neurosci. Res. 86,
1758--1767. doi: 10.1002/jnr.21625
Okano, J., Takigawa, T., Seki, K., Suzuki, S., Shiota, K., and Ishibashi, M. (2005).
Transforming growth factor beta 2 promotes the formation of the mouse
cochleovestibular ganglion in organ culture. Int. J. Dev. Biol. 49, 23--31. doi: 10.
1387/ijdb.041905jo
Ou, H. C., Bohne, B. A., and Harding, G. W. (2000a). Noise damage in the
C57BL/CBA mouse cochlea. Hear. Res. 145, 111--122. doi: 10.1016/s0378-
5955(00)00081-2
Ou, H. C., Harding, G. W., and Bohne, B. A. (2000b). An anatomically based
frequency-place map for the mouse cochlea. Hear. Res. 145, 123--129. doi: 10.
1016/s0378-5955(00)00082-4
Paradies, N. E., Sanford, L. P., Doetschman, T., and Friedman, R. A. (1998).
Developmental expression of the TGF beta s in the mouse cochlea.Mech. Dev.
79, 165--168. doi: 10.1016/S0925-4773(98)00184-1
Park, S.-N., Back, S.-A., Park, K.-H., Seo, J.-H., Noh, H.-I., Akil, O., et al. (2013).
Comparison of functional and morphologic characteristics of mice models of
noise-induced hearing loss. Auris Nasus Larynx 40, 11--17. doi: 10.1016/j.anl.
2011.11.008
Park, J. E., and Barbul, A. (2004). Understanding the role of immune regulation
in wound healing. Am. J. Surg. 187, 11S--16S. doi: 10.1016/s0002-9610(03)
00296-4
Pelton, R. W., Saxena, B., Jones, M., Moses, H. L., and Gold, L. I. (1991).
Immunohistochemical localization of TGF beta 1, TGF beta 2 and TGF beta
3 in the mouse embryo: expression patterns suggest multiple roles during
embryonic development. J. Cell Biol. 115, 1091--1105. doi: 10.1083/jcb.115.
4.1091
Prud’homme, G. J. (2007). Pathobiology of transforming growth factor beta in
cancer, fibrosis and immunologic disease and therapeutic considerations. Lab.
Invest. 87, 1077--1091. doi: 10.1038/labinvest.3700669
Riquelme, R., Cediel, R., Contreras, J., la Rosa Lourdes, R. D., Murillo-Cuesta,
S., Hernandez-Sanchez, C., et al. (2010). A comparative study of age-related
hearing loss in wild type and insulin-like growth factor I deficient mice. Front.
Neuroanat. 4:27. doi: 10.3389/fnana.2010.00027
Rivera, T., Sanz, L., Camarero, G., and Varela-Nieto, I. (2012). Drug delivery to
the inner ear: strategies and their therapeutic implications for sensorineural
hearing loss. Curr. Drug Deliv. 9, 231--242. doi: 10.2174/1567201128003
89098
Rodríguez-de la Rosa, L., López-Herradón, A., Portal-Núñez, S., Murillo-Cuesta,
S., Lozano, D., Cediel, R., et al. (2014). Treatment with N- and C-terminal
peptides of parathyroid hormone-related protein partly compensate the skeletal
abnormalities in igf-I deficient mice. PLoS One 9:e87536. doi: 10.1371/journal.
pone.0087536
Sanchez-Calderon, H., Rodriguez-De La Rosa, L., Milo, M., Pichel, J. G., Holley,
M., and Varela-Nieto, I. (2010). RNA microarray analysis in prenatal mouse
cochlea reveals novel IGF-I target genes: implication of MEF2 and FOXM1
transcription factors. PLoS One 5:e8699. doi: 10.1371/journal.pone.0008699
Sanford, L. P., Ormsby, I., Gittenberger-De Groot, A. C., Sariola, H., Friedman,
R., Boivin, G. P., et al. (1997). TGFbeta2 knockout mice have multiple
Frontiers in Aging Neuroscience | www.frontiersin.org 12 March 2015 | Volume 7 | Article 32
Murillo-Cuesta et al. Targeting TGF-β1 reduces noise-induced damage
developmental defects that are non-overlapping with other TGFbeta knockout
phenotypes. Development 124, 2659--2670.
Sanjabi, S., Zenewicz, L. A., Kamanaka, M., and Flavell, R. A. (2009). Anti-
inflammatory and pro-inflammatory roles of TGF-beta, IL-10 and IL-22 in
immunity and autoimmunity. Curr. Opin. Pharmacol. 9, 447--453. doi: 10.
1016/j.coph.2009.04.008
San-Martin, A., Dotor, J., Martinez, F., and Hontanilla, B. (2010). Effect of the
inhibitor peptide of the transforming growth factor beta (p144) in a new
silicone pericapsular fibrotic model in pigs. Aesthetic Plast. Surg. 34, 430--437.
doi: 10.1007/s00266-010-9475-0
Santiago, B., Gutierrez-Cañas, I., Dotor, J., Palao, G., Lasarte, J. J., Ruiz, J., et al.
(2005). Topical application of a peptide inhibitor of transforming growth
factor-beta1 ameliorates bleomycin-induced skin fibrosis. J. Invest. Dermatol.
125, 450--455. doi: 10.1111/j.0022-202x.2005.23859.x
Sanz, L., Murillo-Cuesta, S., Cobo, P., Cediel, R., Contreras, J., Rivera, T.,
et al. (2015). Swept-sine noise-induced damage as a hearing loss model
for preclinical assays. Front. Neurosci. 7:7. doi: 10.3389/fnagi.2015.
00007
Satoh, H., Billings, P., Firestein, G. S., Harris, J. P., and Keithley, E. M.
(2006). Transforming growth factor beta expression during an inner ear
immune response. Ann. Otol. Rhinol. Laryngol. 115, 81--88. doi: 10.1177/
000348940611500112
Satoh, H., Firestein, G. S., Billings, P. B., Harris, J. P., and Keithley, E. M.
(2002). Tumor necrosis factor-alpha, an initiator and etanercept, an inhibitor of
cochlear inflammation. Laryngoscope 112, 1627--1634. doi: 10.1097/00005537-
200209000-00019
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., et al.
(1992). Targeted disruption of the mouse transforming growth factor-beta 1
gene results in multifocal inflammatory disease. Nature 359, 693--699. doi: 10.
1038/359693a0
Son, E. J., Wu, L., Yoon, H., Kim, S., Choi, J. Y., and Bok, J. (2012). Developmental
gene expression profiling along the tonotopic axis of the mouse cochlea. PLoS
One 7:e40735. doi: 10.1371/journal.pone.0040735
Stamatiou, G. A., and Stankovic, K. M. (2013). A comprehensive network and
pathway analysis of human deafness genes.Otol. Neurotol. 34, 961--970. doi: 10.
1097/mao.0b013e3182898272
Tahera, Y., Meltser, I., Johansson, P., Bian, Z., Stierna, P., Hansson, A. C.,
et al. (2006). NF-kappaB mediated glucocorticoid response in the inner
ear after acoustic trauma. J. Neurosci. Res. 83, 1066--1076. doi: 10.1002/jnr.
20795
Tan, W. J. T., Thorne, P. R., and Vlajkovic, S. M. (2013). Noise-induced
cochlear inflammation. World J. Otorhinolaryngol. 3, 89--99. doi: 10.5319/wjo.
v3.i3.89
Tornabene, S. V., Sato, K., Pham, L., Billings, P., and Keithley, E. M. (2006).
Immune cell recruitment following acoustic trauma. Hear. Res. 222, 115--124.
doi: 10.1016/j.heares.2006.09.004
Vlajkovic, S. M., Lin, S. C., Wong, A. C., Wackrow, B., and Thorne, P. R. (2013).
Noise-induced changes in expression levels of NADPH oxidases in the cochlea.
Hear. Res. 304, 145--152. doi: 10.1016/j.heares.2013.07.012
Wang, Y., Hirose, K., and Liberman, M. C. (2002). Dynamics of noise-induced
cellular injury and repair in the mouse cochlea. J. Assoc. Res. Otolaryngol. 3,
248--268. doi: 10.1007/s101620020028
Weiss, A., and Attisano, L. (2013). The TGFbeta superfamily signaling pathway.
Wiley Interdiscip. Rev. Dev. Biol. 2, 47--63. doi: 10.1002/wdev.86
Wissel, K., Wefstaedt, P., Miller, J. M., Lenarz, T., and Stöver, T. (2006).
Differential brain-derived neurotrophic factor and transforming growth factor-
beta expression in the rat cochlea following deafness. Neuroreport 17,
1297--1301. doi: 10.1097/01.wnr.0000233088.92839.23
Ying, Y. L., and Balaban, C. D. (2009). Regional distribution of manganese
superoxide dismutase 2 (Mn SOD2) expression in rodent and primate spiral
ganglion cells. Hear. Res. 253, 116--124. doi: 10.1016/j.heares.2009.04.006
Yoshida, K., Ichimiya, I., Suzuki, M., and Mogi, G. (1999). Effect of
proinflammatory cytokines on cultured spiral ligament fibrocytes. Hear. Res.
137, 155--159. doi: 10.1016/s0378-5955(99)00134-3
Zhang, F., Dai, M., Neng, L., Zhang, J. H., Zhi, Z., Fridberger, A., et al. (2013).
Perivascular macrophage-like melanocyte responsiveness to acoustic trauma--a
salient feature of strial barrier associated hearing loss. FASEB J. 27, 3730--3740.
doi: 10.1096/fj.13-232892
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2015 Murillo-Cuesta, Rodríguez-de la Rosa, Contreras, Celaya,
Camarero, Rivera and Varela-Nieto. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution and reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Aging Neuroscience | www.frontiersin.org 13 March 2015 | Volume 7 | Article 32
